1. The aging kidney: insights from experimental studies;Baylis;J. Am. Soc. Nephrol.,1998
2. Histologic grading of urothelial carcinoma: a reappraisal;Cheng;Hum. Pathol.,2012
3. FARXIGA® (dapagliflozin) tablets product label. FDA Approved Drug Products, NDA 202293, 10/20/2017. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202293s012lbl.pdf (Last accessed Oct 25 2018).
4. Proliferative and nonproliferative lesions of the rat and mouse urinary system;Frazier;Toxicol. Pathol.,2012
5. Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats;Fukushima;Acta Pathol. Jpn.,1982